Replimune Group, Inc. (REPL)
NASDAQ: REPL · IEX Real-Time Price · USD
10.35
-0.13 (-1.24%)
Jul 26, 2024, 4:00 PM EDT - Market closed
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $707.13 million as of July 26, 2024. Its market cap has decreased by -39.41% in one year.
Market Cap
707.13M
Enterprise Value
364.73M
1-Year Change
-39.41%
Ranking
Category
Stock Price
$10.35
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has increased from $467.50M to $707.13M, an increase of 51.26%. That is a compound annual growth rate of 7.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 643.60M | 29.26% |
| Dec 29, 2023 | 497.90M | -63.20% |
| Dec 30, 2022 | 1.35B | 6.46% |
| Dec 31, 2021 | 1.27B | -27.53% |
| Dec 31, 2020 | 1.75B | 281.78% |
| Dec 31, 2019 | 459.30M | 45.58% |
| Dec 31, 2018 | 315.50M | -32.51% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Savara | 739.96M |
| Arbutus Biopharma | 734.11M |
| Weave Communications | 726.17M |
| ArriVent BioPharma | 726.14M |
| Alumis | 719.00M |
| Definitive Healthcare | 709.38M |
| Paragon 28 | 707.58M |
| REGENXBIO | 703.38M |